Currently, the 1st Resistance Point for this stock is $0.69, with a 2nd Resistance Point sitting at $0.71. Meanwhile, this company’s stock has a 1st Support Level at $0.64 and a 2nd Support Level at $0.61. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Ampio Pharmaceuticals, Inc. (AMPE) was $0.66. Ampio Pharmaceuticals, Inc. (AMPE) stock has lost -$0.03, or -3.81%, in the past five days. In the last full month, these shares have gained $0.26, or 65.36%. In the past three months, this stock’s price has risen by $0.21, or 46.62%. This year-to-date, Ampio Pharmaceuticals, Inc. (AMPE) shares have gained $0.08, or 13.17%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Ampio Pharmaceuticals, Inc. (AMPE) stock, 100% of short-term indicators suggest that these shares are a “ Buy .” Looking further ahead, 50% of long-term indicators suggest that this stock is a “ Buy .”
With 158,645 K shares outstanding, this company currently has a market capitalization of $107,545K. Ampio Pharmaceuticals, Inc. (AMPE) generates annual net income of $33,990 K. This stock has generated a 1-Year Total Return of 33.02%, a 3-Year Total Return of -32.88%, and a 5-year Total Return of -84.05%. This stock’s 5-Year Dividend Growth is 0.00%. Its Annual Dividend Yield is 0.00%, and its Annual Dividend Rate is 0.00.
For the current fiscal quarter, which is set to end in 12/2019, the average earnings estimate is -$0.03 per share. This estimate came from a total of 1 Wall Street Analysts. Of those market experts, the high estimate was -$0.03 and the low estimate was -$0.03. In the year-ago quarter, Ampio Pharmaceuticals, Inc. (AMPE) generated per-share earnings of $0.09. If the analysts are correct about the current quarter’s earnings, the growth will be -133.33%.
Turning our focus now to insider trading activity, there have been 5 purchases (181,464 shares in total) and 0 sale (0 shares in total) in the last 3 months. In the last 6 months, there have been 5 insider buys amounting to 181,464 shares and 0 insider sales amounting to 0 shares. In the past full year, 5 insider purchases were made (involving 181,464 shares) and 0 insider sell-offs equivalent to 0 shares.
Moving onto liquidity, Ampio Pharmaceuticals, Inc. (AMPE) has a Current Ratio of 5.78, a Quick Ratio of 5.78 and a Cash Ratio of 5.48. Looking even further ahead into the future, its Long-Term Debt to Equity is -2,231.44.